Clinical trial
Phase II Study of Pazopanib Maintenance for SCLC
NCT01797874 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Pazopanib Maintenance for SCLC
- Lead sponsor
- Samsung Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- December 31, 2017
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sclc